Ausgabe 9/2024 Including Invited Reviews on Treatment strategy for advanced gastric cancer
Inhalt (20 Artikel)
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval selpercatinib for solid tumor with RET fusion, gumarontinib for non-small cell lung cancer with MET gene exon 14 skipping mutation, momelotinib for myelofibrosis, bexarotene for adult T-cell leukemia/lymphoma, valemetostat for peripheral T-cell lymphoma, and pirtobrutinib for mantle cell lymphoma in Japan
- PMDA Regulatory Update
Noriomi Matsumura, Masaki Mandai
Statistics of bone sarcoma in Japan: report from the population-based cancer registry in Japan
- Cancer Statistics
Koichi Ogura, Chigusa Morizane, Tomoyuki Satake, Shintaro Iwata, Yu Toda, Shudai Muramatsu, Eisuke Kobayashi, Ayumu Arakawa, Chitose Ogawa, Yoko Kato, Takahiro Higashi, Akira Kawai
Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer
- Invited Review Article
Toshihiro Kudo
New therapeutic target molecules for gastric and gastroesophageal junction cancer
- Invited Review Article
Hisato Kawakami
Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancer
- Open Access
- Invited Review Article
Naohiro Nishida, Daisuke Sakai, Taroh Satoh
The miR-199a-5p/HIF1α dual-regulatory axis participates in hypoxia-induced aggressive phenotypes of oral squamous cell carcinoma (OSCC) cells
- Original Article
Xing Chen, Jianjun Yu, Hao Tian, Xu Cai
CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism
- Open Access
- Original Article
Koichi Hayano, Gaku Ohira, Yasunori Matsumoto, Yoshihiro Kurata, Ryota Otsuka, Atsushi Hirata, Takeshi Toyozumi, Kentaro Murakami, Masaya Uesato, Hisahiro Matsubara
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis
- Original Article
Yuan Li, E-er-man-bie-ke Jin-si-han, Cheng Feng, Weili Zhang, Hao Wang, Shaopu Lian, Jianhong Peng, Zhizhong Pan, Binkui Li, Yujing Fang, Zhenhai Lu
Marital status after colorectal surgery in familial adenomatous polyposis: a nationwide multicenter study in Japan
- Original Article
Kenji Fujiyoshi, Tomoya Sudo, Fumihiko Fujita, Shinichi Tanihara, Hideyuki Ishida, Satoki Shichijo, Akiko Chino, Toshiya Nagasaski, Akinari Takao, Kazuhito Sasaki, Kiwamu Akagi, Takaaki Matsubara, Hideki Ueno, Keiji Hirata, Yasuyuki Miyakura, Toshiaki Ishikawa, Eiji Sunami, Yusuke Takahashi, Tatsuro Yamaguchi, Kohji Tanakaya, Naohiro Tomita, Yoichi Ajioka
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)
- Open Access
- Original Article
Yutaka Ogata, Sotaro Sadahiro, Kazuhiro Sakamoto, Takashi Tsuchiya, Takao Takahashi, Hiroki Ohge, Toshihiko Sato, Ken Kondo, Hideo Baba, Michio Itabashi, Masataka Ikeda, Madoka Hamada, Kiyoshi Maeda, Hiroyuki Masuko, Keiichi Takahashi, Mitsuo Kusano, Ichinosuke Hyodo, Junichi Sakamoto, Masataka Taguri, Satoshi Morita
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer
- Original Article
Shingo Maeda, Akira Ouchi, Koji Komori, Takashi Kinoshita, Yusuke Sato, Kei Muro, Hiroya Taniguchi, Toshiki Masuishi, Seiji Ito, Tetsuya Abe, Yasuhiro Shimizu
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
- Original Article
Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort
- Original Article
Makito Miyake, Nobutaka Nishimura, Yuki Oda, Tatsuki Miyamoto, Kota Iida, Kuniaki Inoue, Akira Tachibana, Takanosuke Yoshikawa, Keichi Sakamoto, Mikiko Ohnishi, Fumisato Maesaka, Norimi Takamatsu, Kosuke Mieda, Chihiro Ohmori, Toshihiko Matsubara, Mitsuru Tomizawa, Takuto Shimizu, Kenta Ohnishi, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy
- Original Article
Takeru Fujimoto, Takayuki Goto, Rihito Aizawa, Takashi Ogata, Kiyonao Nakamura, Takayuki Sumiyoshi, Yuki Kita, Kimihiko Masui, Takeshi Sano, Atsuro Sawada, Ryoichi Saito, Shusuke Akamatsu, Takashi Mizowaki, Takashi Kobayashi
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models
- Original Article
Reika Kawabata-Iwakawa, Norihiro Iwasa, Kenichi Satoh, Jacques Colinge, Muneaki Shimada, Satoshi Takeuchi, Hiroyuki Fujiwara, Hidetaka Eguchi, Tetsuro Oishi, Toru Sugiyama, Mitsuaki Suzuki, Kosei Hasegawa, Keiichi Fujiwara, Masahiko Nishiyama
Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging
- Original Article
Kohei Yamaguchi, Tetsushi Tsuruga, Ayumi Taguchi, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori-Uchino, Takayuki Iriyama, Yoko Matsumoto, Osamu Hiraike, Yasushi Hirota, Tomoyuki Fujii, Yutaka Osuga
AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells
- Original Article
Yuki Iida, Mitsuhiko Osaki, Shinya Sato, Runa Izutsu, HeeKyung Seong, Hiroaki Komatsu, Fuminori Taniguchi, Futoshi Okada
Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer
- Original Article
Yuki Kochi, Satoshi Hosoya, Nozomu Yanaihara, Chie Nagata, Rie Honda, Miwako Shimazaki, Kota Yokosu, Takafumi Kuroda, Motoaki Saito, Hiroshi Tanabe, Kyosuke Yamada, Hirokuni Takano, Aikou Okamoto
Prognostic significance of adjuvant chemotherapy in stage I–II endometrial carcinoma patients who underwent lymphadenectomy
- Original Article
Jiro Suzuki, Hiroshi Tanabe, Hirofumi Michimae, Yuki Koike, Misato Kamii, Kazuaki Takahashi, Masataka Takenaka, Motoaki Saito, Hirokuni Takano, Kyosuke Yamada, Aikou Okamoto
The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone
- Original Article
Yu Toda, Koichi Ogura, Shintaro Iwata, Eisuke Kobayashi, Shuhei Osaki, Suguru Fukushima, Masaaki Mawatari, Akira Kawai
